Linnaeus Bioscience Logo

Dedicated to Discovering New Antibiotics

Linnaeus Bioscience Inc. is a contract research organization (CRO) dedicated to the discovery, development, and commercialization of innovative technologies that accelerate drug discovery.

Our Bacterial Cytological Profiling (BCP) platform combined with our proprietary artificial intelligence software provides a revolutionary new approach for discovering and characterizing novel compounds to treat drug resistant bacterial infections.